These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2302831)

  • 1. Reduction of graft-versus-host disease in neonatal F1 hybrid mice.
    DeGiorgi L; Habeshaw JA; Povey S; Matossian-Rogers A
    Clin Exp Immunol; 1990 Jan; 79(1):130-4. PubMed ID: 2302831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of graft-versus-host disease in neonatal F1 hybrid mice by pre-immunisation of their mother with paternal spleen cells.
    DeGiorgi L; Povey S; Habeshaw JA; Davies AJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3045-9. PubMed ID: 2650421
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection of newborn mice from graft versus host disease by maternal pre-immunization.
    DeGiorgi L; Matossian-Rogers A; Festenstein H
    J Immunogenet; 1990; 17(1-2):77-88. PubMed ID: 2212702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM; Katz SI
    J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of graft-versus-host disease on anti-tumor immunity.
    Schreiber KL; Forman J
    J Immunol; 1990 Mar; 144(5):2018-26. PubMed ID: 1968493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P; Vourka-Karussis U; Weiss L; Slavin S
    J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular mechanisms of graft-versus-host disease in a mouse model.
    De Giorgi L; Lowdell MW; Matossian-Rogers A
    Scand J Immunol; 1991 May; 33(5):567-74. PubMed ID: 1827677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal systemic graft-vs-host disease in neonatally tolerant, but not in F1 hybrid mice.
    Vizler C; Jánossy T; Baranyi L; Végh P
    Cell Immunol; 1993 Feb; 146(2):431-7. PubMed ID: 8174181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
    Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
    J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
    J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental model of graft vs. host disease in non-immunosuppressed F1 (CBA/J x C57BL/6) mice.
    Acosta A; Sarmiento ME; Infante JF; Sierra G; Izquierdo L; Capó V; Zamanillo T
    Arch Med Res; 1994; 25(2):151-4. PubMed ID: 7919803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of peripheral immune tolerance uncovers a mouse strain-dependent in situ type of graft tolerance.
    Mysliwietz J; Thierfelder S
    Eur J Immunol; 1999 Jan; 29(1):150-5. PubMed ID: 9933096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of asialo-GM1+ cells from the F1 recipient mice prior to irradiation and transfusion of parental spleen cells prevents mortality to acute graft-versus-host disease and induction of anti-host specific cytotoxic T cells.
    Varkila K
    Clin Exp Immunol; 1987 Sep; 69(3):652-9. PubMed ID: 3499271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of self-macrophage-toxic non-T cells in the MHC-homozygous F1 spleen cells co-cultured with parental cells: possible involvements of host cells in impaired immunity in GVH disease.
    Hosono M; Hosokawa T; Fujiwara M; Katsura Y
    Jpn J Exp Med; 1988 Dec; 58(6):261-7. PubMed ID: 2978270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenetic studies of spontaneous abortion in mice. Preimmunization of females with allogeneic cells.
    Kiger N; Chaouat G; Kolb JP; Wegmann TG; Guenet JL
    J Immunol; 1985 May; 134(5):2966-70. PubMed ID: 3980987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells.
    Pals ST; Gleichmann H; Gleichmann E
    J Exp Med; 1984 Feb; 159(2):508-23. PubMed ID: 6229596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.